Med. Pro Praxi 2010; 7(8-9): 313-317

Irritable bowel syndrome

doc. MUDr. Bohumil Seifert, Ph.D.
Ústav všeobecného lékařství 1. LF UK Praha

Complaints related to the lower gastrointestinal tract are among the most common reasons for seeing a general practitioner as well as

a common reason for referral to specialist care. The patients who consult a physician only represent a fraction of those whose complaints

could be characterised as irritable bowel syndrome or other functional disorders of the gastrointestinal tract. The reasons why the majority

of patients do not consult their physician may be the bearable nature of their complaints or little faith in medical help. Patients with

functional disorders, including differential diagnosis, pose a burden for both general practitioners and gastroenterologists with the

burden of the latter being dependent to a high degree on the tolerance of the former‘s diagnostic uncertainty and confidence to establish

a positive diagnosis of a functional disorder. In order to help general practitioners in their approach to patients with these complaints, the

„Lower dyspeptic syndrome“ (1) guideline was issued by the Society of General Practice of the J. E. Purkyně Czech Medical Association

in 2005. It is the personality of the physician and his ability to explain the problem and reassure the patient that is particularly involved

in the therapeutic approach to patients with irritable bowel syndrome. Although the efficacy of pharmacotherapy is limited, drugs are

available that can prevent or alleviate the predominant symptoms such as abdominal pain, diarrhoea or constipation. Nonpharmacological,

dietary and lifestyle measures and/or psychological therapy and the combinations of the above are part of the treatment.

Keywords: irritable bowel syndrome, general practitioner, diarrhoea, constipation

Published: October 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Seifert B. Irritable bowel syndrome. Med. praxi. 2010;7(8-9):313-317.
Download citation

References

  1. Seifert B, Lukáš K, Charvátová E, Vojtíšková J, Koudelka T, Hep A, Bureš J, Jirásek V, Dítě P. Dolní dyspeptický syndrom. Doporučený diagnostický a terapeutický postup pro všeobecné praktické lékaře. Časopis lékařů českých, 2007; 146(1): 17-23. Go to PubMed...
  2. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther. 2003; 17(5): 643-650. Go to original source... Go to PubMed...
  3. Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000; 46(1): 78-82. Go to original source... Go to PubMed...
  4. Hillila MT, Farkilla MA. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a nonselected adult population. Aliment Pharmacol ther 2004; 20(3): 339-345. Go to original source... Go to PubMed...
  5. Seifert B, Dítě P, Vojtíšková J. Jak hodnotí gastroenterologové postupy praktických lékařů v České republice - příspěvek k mezioborové spolupráci, Časopis lékařů českých 144, 2005; 6: 424-428.
  6. Drossman DA, et al. The functional Gastrointestinal Disoredsr and the Rome III Process, Gastroenterology, 2006; 130(5): 1377-1390. Go to original source... Go to PubMed...
  7. Rubin G, de Wit N, Meineche-Schmidt V, Seifert B, Hall N, Hungin P. Identification and diagnosis of patients with irritable bowel syndrome in primary care: nominal group technique, Gut 2005; Suppl VII: A3.
  8. Seifert B, Rubin G, de Wit N, Lionis C, Hall N, Hungin P, Jones R, Palka M, Mendive J. Management of Common Gastrointestinal Disorders in General Practice. ESPCG Survey in Six European Countries, Digestive and Liver Disease 2008; 40: 659-666. Go to original source... Go to PubMed...
  9. Brandt LJ, Locke GR, Olden K, et al. An evidence based approach to the management of irritable bowel syndrome in North America. Am J Gastro 2002; 97(suppl): S1-24. Go to original source... Go to PubMed...
  10. Quartero AO, Meiniche-Schmidt V, Muris J, Rubin G, de Wit N. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database of Systematic Review 2005. Go to original source...
  11. Kennedy T. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: Randomised controlled trial. BMJ: British-Medical-Journal 2005; 331(7514). Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.